Orbit Alpha Issue 27 · 18 Oct 2026

A Spectrum Land Grab Rattles the Satellite Complex

Market Overview

🌎 A Spectrum Land Grab Rattles the Satellite Complex

This was a risk-off week for space equities more than it was a string of isolated company stories. SpaceX's roughly $8 billion deal to buy nationwide 800 MHz spectrum from Grain Management, which surfaced around October 12 and still needs FCC sign-off, raised fears across the sector that SpaceX is about to become a far better-capitalized direct competitor in direct-to-device connectivity. Add in lingering worry over SpaceX's reported appetite for tens of billions in new debt to fund Nvidia chip purchases and Rocket Lab's own bad news on its next rocket, and most of the sector spent the week trading down even where the underlying corporate news was fine or good. That said, the week wasn't short on developments. Several names landed real contracts, filings, and analyst calls worth tracking individually below, and not every stock moved with the tape.

SpaceX (SPCX)
SpaceX's biggest story this week wasn't financial, it was geopolitical. On October 13, Ukrainian officials disclosed that Starshield, the military-grade variant of Starlink used on the battlefield, has been restricting connectivity for terminals moving faster than roughly 100 mph, a serious problem for drone operations that reportedly drops the connection for ten to twenty seconds even below that threshold. The next day, October 14, Elon Musk responded on X to Ukraine's former defense minister Mykhailo Fedorov, stating that Starshield systems are "owned and controlled" by the U.S. government and that "any limits on speed or usage are decided by the US military and ultimately POTUS." He added that commercial Starlink cannot be used for offensive military strikes. By October 16, presidential adviser Serhii Beskrestnov told reporters Ukraine is in "active negotiations with the Pentagon, SpaceX and the U.S. government" to lift the cap, per the Associated Press, while President Trump denied personally ordering the restriction, saying "it wasn't me, and I don't think it was Elon."
On the market side, Evercore ISI analyst Kutgun Maral raised his SPCX price target to $275 from $230 on October 16, maintaining Outperform and implying roughly 87% upside from the stock's mid-$140s level. Maral's thesis leans on Starship's reuse trajectory following Flight 14's successful orbital run, a projected $104 billion in annualized recurring revenue by year-end 2026, and a raised FY2029 adjusted EBITDA forecast of $266 billion. SpaceX also confirmed on October 16 that it will report third-quarter earnings after the close on Tuesday, October 20, and Musk told reporters on October 13 that the next Starship flight, Flight 15, will attempt the program's first ship-to-tower catch of the upper stage, targeted roughly four to six weeks out. On the launch manifest, SpaceX flew CRS-35, its 35th NASA cargo resupply mission, on October 13, and the classified USSF-481 national security mission from Vandenberg Space Force Base on October 15.

Rocket Lab (RKLB)
Rocket Lab's week was dominated by bad news on its most important program. On October 15, the company delayed Neutron's debut launch from late 2026 into 2027, after inspectors found voids in a newly cured carbon-fibre forward propellant dome during manufacturing. CEO Peter Beck told Space.com, "We believe Neutron is going to be a game-changer," but added that "possible success isn't our standard," with a fix and requalification targeted to wrap by the first quarter of 2027. The stock sold off sharply on the news, and a wave of analysts cut targets in response: Citizens JMP trimmed its target to $90 from $130 while keeping Outperform, KeyBanc cut to $100 from $135, and Clear Street cut to $105 from $129. Not everyone turned bearish. Roth Capital reiterated Buy at $110, arguing that Rocket Lab's quality-over-speed approach pays off once Neutron flies reliably, and Cantor Fitzgerald reiterated Overweight at $122. On the launch side, Rocket Lab outlined its next three Electron missions as it builds toward flight number 100, including "We're Not Hawking Around," a three-satellite HawkEye 360 cluster mission targeted for October 21.

AST SpaceMobile (ASTS)
AST SpaceMobile had one of the roughest weeks in the sector, almost entirely downstream of someone else's deal. SpaceX's roughly $8 billion agreement to buy Grain Management's spectrum, which surfaced around October 12, raised fears that SpaceX will become a far better-capitalized direct competitor in direct-to-device service. B. Riley downgraded ASTS to Neutral the same day, cutting its target to $65 from $85 and citing pricing pressure from cheaper rivals including Viasat. Piper Sandler followed on October 13 with a downgrade to Neutral from Overweight and a target cut to $54 from $98, pointing to reduced confidence in AST's 2026 and 2027 satellite deployment pace given SpaceX's newly spectrum-fueled competitive threat; the note also flagged AST's $1.3 billion contracted revenue backlog and its FY2026 revenue guidance of $150 million to $200 million. The stock fell to a fresh 52-week intraday low of $39.87 on October 16.
Not every voice was bearish. At the Network X conference in Vienna on October 13, Vodafone Group Ventures director Tim Boddy, who also chairs Satellite Connect Europe, the Vodafone-AST joint venture, pushed back on the panic, saying "it's not obvious to me that SpaceX would do the same in Europe as it did in the U.S." Satellite-comms analyst Tim Farrar argued separately this week that AST may need to follow Rocket Lab's playbook, which closed a roughly $8 billion deal to acquire satellite operator Iridium earlier this year, by acquiring a launch company or satellite operator of its own, floating Firefly Aerospace as one example. Separately, law firm Bronstein, Gewirtz & Grossman announced on October 16 a securities class action against AST SpaceMobile covering the period from March 4, 2025 through July 15, 2026, alleging the company understated its capital needs and overstated the durability of its direct-to-device market position.

Intuitive Machines (LUNR)
Zacks Research downgraded the stock from Hold to Strong Sell on October 14, and shares fell as much as 9.5% that day to close at $11.02. Two days later, on October 16, Macquarie initiated coverage with an Outperform rating and a $25 price target, part of a six-stock aerospace and defense initiation batch, though the stock continued to slide regardless, trading down near $10.78 that day. The broader pressure traces partly to NASA pushing back the start of its CLPS 2.0 contract award to November 7, which prompted some profit-taking after the stock's rally earlier in the month, compounded by sector-wide jitters tied to reports of SpaceX seeking tens of billions in new debt to fund Nvidia chip purchases.

Virgin Galactic (SPCE)
Goldman Sachs analyst Noah Poponak cut his price target to $3.05 on October 12 while maintaining a Hold rating. Two days later, on October 14, the company announced a 24-month Cooperative Research and Development Agreement with the U.S. Air Force Research Laboratory's Space Warfare Directorate at Kirtland Air Force Base to gather space-weather data from the mesosphere and lower thermosphere using sensors integrated onto its next-generation Spaceship. Shares drifted lower through the week, closing around $2.43 to $2.44 by October 16.

Redwire (RDW)
On October 12, the final pair of Redwire-built ROSA solar array wings launched to the International Space Station aboard the same SpaceX CRS-35 mission carrying NASA's cargo, completing an eight-wing power-modernization effort for the station; Redwire Space president Mike Gold credited customer Boeing in the company's release. On October 15, Redwire secured roughly $13.8 million in additional purchase orders for its Stalker unmanned aircraft systems from the U.S. Army National Guard Bureau, supporting training for the Army's new Tactical UAS Specialist role. The same day, Piper Sandler initiated coverage with a Neutral rating and an $11 price target, well below the broader analyst consensus near $14.28, citing uncertainty about whether Redwire can reach critical mass in either the space or defense market. Shares fell roughly 6% on October 16 to close near $8.38.

Viasat (VSAT)
Needham raised its price target to $105 from $90 on October 14 while maintaining Buy, citing the value of Viasat's spectrum holdings, a theme that's been running through sector coverage all month. Separately, six Form 4 filings hit SEC EDGAR on October 13 showing performance-based stock options originally granted in November 2023 vesting additional tranches for several executives, including chairman and CEO Mark Dankberg, after the stock cleared certain price hurdles. Viasat Government president Craig Miller also exercised and sold 11,893 shares the same day under a pre-arranged Rule 10b5-1 trading plan at a weighted-average price in the low $70s, a modest profit-take against a $15.96 strike price rather than an open-market signal of concern.

MDA Space (MDA)
On October 13, Czechoslovak Group, the Czech defence and arms conglomerate controlled by Michal Strnad, took a 9.5% anchor stake in MDA, roughly 15.4 million shares, becoming the company's largest shareholder; the stake was disclosed in a Schedule 13D filed with the SEC on October 14. The shares came via physical settlement of a forward contract with Morgan Stanley Europe originally signed in July 2026, with the Canadian government's investment-review approval for that settlement granted October 8. Reuters, MarketWatch, and the Wall Street Journal all put the stake's value at roughly C$618 to 620 million, or about US$434 million; one lone outlet cited a materially higher US$656 million figure that doesn't reconcile with the consensus and should be treated with caution. CEO Mike Greenley welcomed CSG as a strategic investor, while the Czech firm signalled interest in European manufacturing co-investment and joint strategic acquisitions. MDA shares reportedly jumped in premarket trading on the news.

Planet Labs (PL)
On October 13, Planet's European subsidiary Sinergise was selected by the European Space Agency to build a Space Resilience Node pilot program for Slovenia's civil protection agency, automating satellite change-detection for disaster response over a 12-month pilot. The same week brought two insider sales under existing 10b5-1 plans: board member and former Space Force chief of space operations John "Jay" Raymond sold 6,494 shares on October 13 at a weighted-average price of $15.23, and director Kristen Robinson sold 40,000 shares on October 15 for $565,560 at a weighted-average price of $14.14. Goldman Sachs trimmed its price target to $22 from $24 on October 12 while keeping Hold. Shares fell roughly 6.7% on October 16 amid a broader growth-stock selloff that also hit several other names in this basket the same day.

BlackSky Technology (BKSY)
On October 15, the company extended its Space Domain Awareness partnership with HEO, adding a new non-earth-imaging contract described only as "seven-figure annual" in value, now in its third year after starting as a smaller pilot in 2024. Like most of the basket, BKSY shares slid through the week, falling from an October 12 close near $19.86 to roughly $17.32 by October 16, in line with the same sector-wide pressure affecting Rocket Lab, AST SpaceMobile, and Redwire.

Takeaway
Zoom out, and this was a sector-wide risk-off week more than a string of isolated stories. SpaceX's roughly $8 billion spectrum deal with Grain Management, layered on top of lingering worry about its reported appetite for new debt to fund Nvidia chip purchases, rattled sentiment across the whole direct-to-device and small-satellite complex, hitting AST SpaceMobile hardest but dragging down Planet Labs, Firefly Aerospace, BlackSky, and Intuitive Machines as well. Rocket Lab's Neutron delay added a company-specific setback on top of that macro pressure. Not every name moved with the tape: Evercore's bullish SpaceX call, Needham's bullish Viasat call, and MDA's new anchor shareholder all point to pockets of real optimism underneath the week's volatility. Globalstar's story remains frozen in place, still trading at a discount to the pending $90-per-share Amazon buyout price agreed back in April while the deal awaits FCC review. Next week brings two real catalysts: SpaceX reports third-quarter earnings after the close on October 20, just days before its next lockup tranche unlocks on October 24, and NASA is now expected to award its CLPS 2.0 contract on November 7, a decision Intuitive Machines investors in particular will be watching closely.

Consensus Prices

Launch Watch

• Oct 19 · SpaceX · Falcon 9 · Bandwagon-5 rideshare mission · Cape Canaveral Space Force Station, FL
• Oct 19 · JAXA/MHI · H3-24L · MMX, Martian Moons eXploration Phobos sample-return mission · Tanegashima Space Center, Japan
• Oct 20 · SpaceX · Falcon 9 · Starlink Group 15-15 · Vandenberg Space Force Base, CA
• NET Oct 21 · Rocket Lab · Electron · "We're Not Hawking Around," a three-satellite HawkEye 360 cluster · Māhia Peninsula, New Zealand
• Oct 21 · Galactic Energy · Ceres-1S · Sea-launch mission, payload TBD · Yellow Sea, China
• Oct 22 · CASC · Long March 8A · Payload TBD · Wenchang Space Launch Site, China
• NET Oct 23 · CASC · Long March 4B · Payload TBD · Jiuquan Satellite Launch Center, China
• Oct 24 · SpaceX · Falcon 9 · Starlink Group 15-16 · Vandenberg Space Force Base, CA
• NET Oct 29 · ULA · Vulcan VC6L (Cert-3) · Amazon Leo LV-01, 40 Kuiper satellites · Cape Canaveral Space Force Station, FL
• NET late Oct/Nov (date unsettled) · Arianespace · Ariane 6 · Amazon Leo LE-04, 35 Kuiper satellites · Guiana Space Centre, Kourou. Sources disagree on timing, with some trackers showing November 23 instead; treat the date as soft either way.
• NET Nov 4 · Rocket Lab · Electron · "The Sea God Surveys," iQPS mission · Māhia Peninsula, New Zealand
• NET October · ISRO · GSLV Mk II (GSLV-F18) · NVS-03/IRNSS-1L navigation satellite · Satish Dhawan Space Centre, India

Orbit Focus

🎯NEUTRON SLIPS TO 2027: WHAT ROCKET LAB'S DELAY IS REALLY TELLING INVESTORS

The most useful story in the space-equity complex this week wasn't about SpaceX at all. It was about what happens to a stock's narrative when the Street has to choose between rewarding patience and punishing a missed date, and Rocket Lab gave investors a clean test case.

The flaw. On October 15, Rocket Lab disclosed that it is pushing Neutron's debut launch from late 2026 into 2027. The cause was mechanical, not financial: inspectors found voids in a newly cured carbon-fiber forward propellant dome during manufacturing, and the company decided to fix and requalify the part rather than fly around the defect. CEO Peter Beck told Space.com that "we believe Neutron is going to be a game-changer," but was explicit about why the company chose the slower path: "possible success isn't our standard." Rocket Lab is targeting completion of the fix and requalification testing by the first quarter of 2027.

The Street's split verdict. Analysts broke cleanly into two camps within 48 hours. The bears cut hard: Citizens JMP trimmed its target to $90 from $130 while still keeping an Outperform rating, KeyBanc cut to $100 from $135, and Clear Street cut to $105 from $129. The bulls held their ground: Roth Capital reiterated Buy at $110, arguing explicitly that Rocket Lab's quality-over-speed approach pays off once Neutron is actually flying reliably, and Cantor Fitzgerald reiterated Overweight at $122. That's a roughly $35 spread between the most bearish and most bullish targets issued in the same week on the same piece of news, which tells you this isn't really a disagreement about the facts. It's a disagreement about how much credit a pre-revenue rocket program deserves for choosing caution over a launch date.

A pattern, not a surprise. The market had already started flinching before Thursday's announcement. TD Cowen cut its Rocket Lab target to $90 from $120 on October 9, nearly a week before the dome issue became public, a sign that at least some analysts were pricing in schedule risk on Neutron ahead of any specific disclosed cause. That matters for how you read this delay: it isn't a bolt from nowhere, it's the latest data point in a pattern of the Street gradually discounting Neutron's original timeline even before Rocket Lab confirmed there was a reason to.

The hedge. Rocket Lab's answer to "what if Neutron keeps slipping" has increasingly been to not depend on Neutron alone. The company's roughly $8 billion agreement to acquire satellite operator Iridium, struck back in June and still targeted to close around mid-2027, gives Rocket Lab a second major earnings driver that has nothing to do with whether Neutron flies on time. It's the same logic Tim Farrar, the satellite-comms analyst, pointed to elsewhere this week when he suggested AST SpaceMobile might need to pursue a similar diversifying acquisition of its own: a single-vehicle or single-constellation bet is a concentrated bet, and Rocket Lab is already running the diversification playbook that other companies in this basket are only now being asked whether they should copy.

What Electron is still doing while Neutron waits. It's worth remembering that Rocket Lab's existing, proven vehicle kept winning business right through this news cycle. Just two weeks before the Neutron delay, Japanese earth-observation company Synspective placed an order for 20 additional Electron launches, the largest single Electron order in Rocket Lab's history, bringing Synspective's total commitment to 47 launches running from 2028 through 2031. Rocket Lab didn't disclose a dollar figure for the order, though at least one outlet estimated it in the neighborhood of $168 million using Electron's published list pricing, a figure that should be treated as an estimate rather than a confirmed number. The point isn't the exact dollar amount. It's that Electron's order book kept growing in the same month Neutron's timeline slipped, which is the clearest evidence that customers still trust Rocket Lab's execution on the vehicle it has actually flown dozens of times, even while some of them wait longer for the one it hasn't flown at all.

Takeaway. Rocket Lab's Neutron delay is a useful reminder that in this sector, the stock reaction to a schedule slip depends almost entirely on whether investors see the underlying business as a single bet or a portfolio of bets. The bears are pricing Neutron as the whole investment case and marking it down for lost time. The bulls are pricing Rocket Lab as Electron's cash flow, plus Iridium's diversification, plus a Neutron option that's worth less today but not worth zero. Both views can be internally consistent, which is exactly why the price targets issued this week range from $90 to $122 on the same set of facts. The next real test isn't another analyst note, it's whether Rocket Lab hits its own first-quarter 2027 requalification target without a second slip, since a second delay would make it much harder for the bulls' patience argument to hold.

This newsletter is for informational purposes only and is not investment, legal, or financial advice. We believe our sources are reliable but can't guarantee accuracy or completeness, and all figures should be independently verified before you rely on them.

Previous: Issue 26: SpaceX Turns Carrier, and the Direct-to-Device Trade Pays the Price